[Hepatotoxicity of nitrostigmine (E 605 forte) and obidoxime (Toxogonin) in dogs].
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000931:Antidotes; D001219:Aspartate Aminotransferases / Q000097:blood; D001285:Atropine / Q000627:therapeutic use; D002802:Cholinesterases / Q000097:blood; D004285:Dogs; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000187:drug effects*; D008297:Male; D010278:Parathion / Q000633:toxicity*; D011220:Pralidoxime Compounds / Q000633:toxicity*; D013385:Succinate Dehydrogenase / Q000097:blood
D000931:Antidotes; D011220:Pralidoxime Compounds; D010278:Parathion; D001285:Atropine; D007770:L-Lactate Dehydrogenase; D013385:Succinate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D002802:Cholinesterases
Zur Frage der Lebertoxicität von Nitrostigmin (E 605 forte) und Obidoxim (Toxogonin) an Hunden.